Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Stage-specific therapy for cancer of the oesophagus: a new 'cancer of the elderly'.

Krasna MJ.

Drugs Aging. 2009;26(3):185-94. doi: 10.2165/00002512-200926030-00001.

PMID:
19358615
3.

Adjuvant and neoadjuvant therapy for gastric cancer.

Kelsen DP.

Semin Oncol. 1996 Jun;23(3):379-89. Review.

PMID:
8658222
4.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
5.

Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.

Kokka F, Bryant A, Brockbank E, Powell M, Oram D.

Cochrane Database Syst Rev. 2015 Apr 7;(4):CD010260. doi: 10.1002/14651858.CD010260.pub2. Review.

PMID:
25847525
6.

Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer.

Courrech Staal EF, Aleman BM, Boot H, van Velthuysen ML, van Tinteren H, van Sandick JW.

Br J Surg. 2010 Oct;97(10):1482-96. doi: 10.1002/bjs.7175. Review.

PMID:
20645400
7.

Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.

Luu TD, Gaur P, Force SD, Staley CA, Mansour KA, Miller JI Jr, Miller DL.

Ann Thorac Surg. 2008 Apr;85(4):1217-23; discussion 1223-4. doi: 10.1016/j.athoracsur.2007.11.070.

PMID:
18355499
8.

Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.

Klevebro F, Lindblad M, Johansson J, Lundell L, Nilsson M.

Br J Surg. 2016 Dec;103(13):1864-1873. doi: 10.1002/bjs.10304. Epub 2016 Sep 30.

PMID:
27689845
9.

Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer.

Bystricky B, Okines AF, Cunningham D.

Drugs. 2011 Mar 26;71(5):541-55. doi: 10.2165/11585460-000000000-00000. Review.

PMID:
21443280
10.

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.

Malthaner RA, Wong RK, Rumble RB, Zuraw L; Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

BMC Med. 2004 Sep 24;2:35. Review.

12.

Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer.

Deng HY, Wang WP, Wang YC, Hu WP, Ni PZ, Lin YD, Chen LQ.

Eur J Cardiothorac Surg. 2017 Mar 1;51(3):421-431. doi: 10.1093/ejcts/ezw315. Review.

PMID:
27694253
13.

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.

Mariette C, Piessen G, Triboulet JP.

Lancet Oncol. 2007 Jun;8(6):545-53. Review.

PMID:
17540306
14.

Esophageal cancer: adjuvant therapy.

Ku GY, Ilson DH.

Cancer J. 2007 May-Jun;13(3):162-7. Review.

PMID:
17620765
15.

Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer.

McDonnell CO, Bouchier-Hayes DJ, Toomey D, Foley D, Kay EW, Leen E, Walsh TN.

Br J Surg. 2003 Nov;90(11):1373-8.

PMID:
14598417
16.

[Multimodal therapy of esophageal cancer].

Hartwig W, Strobel O, Lordick F, B├╝chler MW, Werner J.

Z Gastroenterol. 2008 Oct;46(10):1207-13. doi: 10.1055/s-2008-1027466. Epub 2008 Oct 20. Review. German. Erratum in: Z Gastroenterol. 2008 Nov;46(11):1335. Hartung, W [corrected to Hartwig, W].

PMID:
18937192
17.
18.

Preoperative chemotherapy for resectable thoracic esophageal cancer.

Malthaner R, Fenlon D.

Cochrane Database Syst Rev. 2001;(1):CD001556. Review. Update in: Cochrane Database Syst Rev. 2003;(4):CD001556.

PMID:
11279723
19.

Multimodal treatment of oesophageal carcinoma.

Iizuka T.

Ann Chir Gynaecol. 1995;84(2):216-21. Review.

PMID:
7574383
20.

Systemic treatment of oesophageal cancer.

Richel DJ, Vervenne WL.

Eur J Gastroenterol Hepatol. 2004 Mar;16(3):249-54. Review.

PMID:
15195887

Supplemental Content

Support Center